PURPOSE: Most prostate cancer in African American men lacks the ETS (E26 transforming specific) family fusion event (ETS-). We aimed to establish clinically relevant biomarkers in African American men by studying ETS dependent gene expression patterns to identified race specific genes predictive of outcomes. MATERIALS AND METHODS: Two multicenter cohorts of a total of 1,427 men were used for the discovery and validation (635 and 792 men, respectively) of race specific predictive biomarkers. We used false discovery rate adjusted q values to identify race and ETS dependent genes which were differentially expressed in African American men who experienced biochemical recurrence within 5 years. Principal component modeling along with survival analysis was done to assess the accuracy of the gene panel in predicting recurrence. RESULTS: We identified 3,047 genes which were differentially expressed based on ETS status. Of these genes 362 were differentially expressed in a race specific manner (false discovery rate 0.025 or less). A total of 81 genes were race specific and over expressed in African American men who experienced biochemical recurrence. The final gene panel included APOD, BCL6, EMP1, MYADM, SRGN and TIMP3. These genes were associated with 5-year biochemical recurrence (HR 1.97, 95% CI 1.27-3.06, p = 0.002) and they improved the predictive accuracy of clinicopathological variables only in African American men (60-month time dependent AUC 0.72). CONCLUSIONS: In an effort to elucidate biological features associated with prostate cancer aggressiveness in African American men we identified ETS dependent biomarkers predicting early onset biochemical recurrence only in African American men. Thus, these ETS dependent biomarkers representing ideal candidates for biomarkers of aggressive disease in this patient population.
PURPOSE: Most prostate cancer in African American men lacks the ETS (E26 transforming specific) family fusion event (ETS-). We aimed to establish clinically relevant biomarkers in African American men by studying ETS dependent gene expression patterns to identified race specific genes predictive of outcomes. MATERIALS AND METHODS: Two multicenter cohorts of a total of 1,427 men were used for the discovery and validation (635 and 792 men, respectively) of race specific predictive biomarkers. We used false discovery rate adjusted q values to identify race and ETS dependent genes which were differentially expressed in African American men who experienced biochemical recurrence within 5 years. Principal component modeling along with survival analysis was done to assess the accuracy of the gene panel in predicting recurrence. RESULTS: We identified 3,047 genes which were differentially expressed based on ETS status. Of these genes 362 were differentially expressed in a race specific manner (false discovery rate 0.025 or less). A total of 81 genes were race specific and over expressed in African American men who experienced biochemical recurrence. The final gene panel included APOD, BCL6, EMP1, MYADM, SRGN and TIMP3. These genes were associated with 5-year biochemical recurrence (HR 1.97, 95% CI 1.27-3.06, p = 0.002) and they improved the predictive accuracy of clinicopathological variables only in African American men (60-month time dependent AUC 0.72). CONCLUSIONS: In an effort to elucidate biological features associated with prostate cancer aggressiveness in African American men we identified ETS dependent biomarkers predicting early onset biochemical recurrence only in African American men. Thus, these ETS dependent biomarkers representing ideal candidates for biomarkers of aggressive disease in this patient population.
Authors: Cristina Magi-Galluzzi; Toyonori Tsusuki; Paul Elson; Kelly Simmerman; Chris LaFargue; Raquel Esgueva; Eric Klein; Mark A Rubin; Ming Zhou Journal: Prostate Date: 2010-09-28 Impact factor: 4.104
Authors: Alba Torres; Mohammed Alshalalfa; Scott A Tomlins; Nicholas Erho; Ewan A Gibb; Jijumon Chelliserry; Lony Lim; Lucia L C Lam; Sheila F Faraj; Stephania M Bezerra; Elai Davicioni; Kasra Yousefi; Ashley E Ross; George J Netto; Edward M Schaeffer; Tamara L Lotan Journal: J Mol Diagn Date: 2017-03-21 Impact factor: 5.568
Authors: Samson W Fine; Anuradha Gopalan; Margaret A Leversha; Hikmat A Al-Ahmadie; Satish K Tickoo; Qin Zhou; Jaya M Satagopan; Peter T Scardino; William L Gerald; Victor E Reuter Journal: Mod Pathol Date: 2010-06-18 Impact factor: 7.842
Authors: Sven Perner; Matthias D Hofer; Robert Kim; Rajal B Shah; Haojie Li; Peter Möller; Richard E Hautmann; Juergen E Gschwend; Rainer Kuefer; Mark A Rubin Journal: Hum Pathol Date: 2007-02-22 Impact factor: 3.466
Authors: Kosj Yamoah; Michael H Johnson; Voleak Choeurng; Farzana A Faisal; Kasra Yousefi; Zaid Haddad; Ashley E Ross; Mohammed Alshalafa; Robert Den; Priti Lal; Michael Feldman; Adam P Dicker; Eric A Klein; Elai Davicioni; Timothy R Rebbeck; Edward M Schaeffer Journal: J Clin Oncol Date: 2015-07-20 Impact factor: 44.544
Authors: Sven Perner; Juan-Miguel Mosquera; Francesca Demichelis; Matthias D Hofer; Pamela L Paris; Jeff Simko; Colin Collins; Tarek A Bismar; Arul M Chinnaiyan; Angelo M De Marzo; Mark A Rubin Journal: Am J Surg Pathol Date: 2007-06 Impact factor: 6.394
Authors: Anders E Berglund; Robert J Rounbehler; Travis Gerke; Shivanshu Awasthi; Chia-Ho Cheng; Mandeep Takhar; Elai Davicioni; Mohammed Alshalalfa; Nicholas Erho; Eric A Klein; Stephen J Freedland; Ashley E Ross; Edward M Schaeffer; Bruce J Trock; Robert B Den; John L Cleveland; Jong Y Park; Jasreman Dhillon; Kosj Yamoah Journal: Prostate Cancer Prostatic Dis Date: 2018-10-26 Impact factor: 5.554
Authors: Walter Rayford; Alp Tuna Beksac; Jordan Alger; Mohammed Alshalalfa; Mohsen Ahmed; Irtaza Khan; Ugo G Falagario; Yang Liu; Elai Davicioni; Daniel E Spratt; Edward M Schaeffer; Felix Y Feng; Brandon Mahal; Paul L Nguyen; Robert B Den; Mark D Greenberger; Randy Bradley; Justin M Watson; Matthew Beamer; Lambros Stamatakis; Darrell J Carmen; Shivanshu Awasthi; Jonathan Hwang; Rachel Weil; Harri Merisaari; Nihal Mohamed; Leslie A Deane; Dimple Chakravarty; Kamlesh K Yadav; Kosj Yamoah; Sujit S Nair; Ashutosh K Tewari Journal: Commun Biol Date: 2021-06-03
Authors: Kevin H Kensler; Shivanshu Awasthi; Mohamed Alshalalfa; Bruce J Trock; Stephen J Freedland; Michael R Freeman; Sungyong You; Brandon A Mahal; Robert B Den; Adam P Dicker; R Jeffrey Karnes; Eric A Klein; Priti Lal; Yang Liu; Elai Davicioni; Walter Rayford; Kosj Yamoah; Timothy R Rebbeck Journal: Eur Urol Open Sci Date: 2022-04-26
Authors: Stephen J Freedland; Kosj Yamoah; Shivanshu Awasthi; Anders Berglund; Julieta Abraham-Miranda; Robert J Rounbehler; Kevin Kensler; Amparo Serna; Adriana Vidal; Sungyong You; Michael R Freeman; Elai Davicioni; Yang Liu; R Jeffrey Karnes; Eric A Klein; Robert B Den; Bruce J Trock; Joshua D Campbell; David J Einstein; Raavi Gupta; Steven Balk; Priti Lal; Jong Y Park; John L Cleveland; Timothy R Rebbeck Journal: Clin Cancer Res Date: 2020-10-09 Impact factor: 13.801
Authors: Hong Yuen Wong; Quanhu Sheng; Amanda B Hesterberg; Sarah Croessmann; Brenda L Rios; Khem Giri; Jorgen Jackson; Adam X Miranda; Evan Watkins; Kerry R Schaffer; Meredith Donahue; Elizabeth Winkler; David F Penson; Joseph A Smith; S Duke Herrell; Amy N Luckenbaugh; Daniel A Barocas; Young J Kim; Diana Graves; Giovanna A Giannico; Jeffrey C Rathmell; Ben H Park; Jennifer B Gordetsky; Paula J Hurley Journal: Nat Commun Date: 2022-10-13 Impact factor: 17.694
Authors: Kosj Yamoah; Priti Lal; Shivanshu Awasthi; Arash O Naghavi; Robert J Rounbehler; Travis Gerke; Anders E Berglund; Julio M Pow-Sang; Edward M Schaeffer; Jasreman Dhillon; Jong Y Park; Timothy R Rebbeck Journal: Prostate Date: 2020-11-03 Impact factor: 4.104